Clinical Trial

Reduced Dissemination of Tumor Cells With Primary Ligation of the Inferior Mesenteric Vein in Rectal Cancer Patients.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 15, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Effect of ligation sequence of the inferior mesenteric artery and vein on circulating tumor cells and survival in laparoscopic rectal cancer surgery: a prospective, multicenter, randomized controlled study (ARVECTS)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-03-29; most recent amendment 2024-02-14.
Trial Details
NCT Number NCT05807646
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Collaborators: Sichuan Provincial People's Hospital, The Second People's Hospital of Chengdu
Conditions Rectal Cancer
Enrollment 268 participants
Start Date 2025-01
Primary Completion 2025-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-02-15